FDA approves Belzutifan, the first oral therapy for advanced, rare tumors.
New FDA approvals are changing cancer treatment.
FDA approves lifileucel, a TIL cellular therapy for advanced melanoma.
Gut bacteria can predict and improve cancer treatment response.
